Cara Therapeutics CMO Joana Goncalves resigns effective April 16, 2024

Tvardi Therapeutics, Inc.

Dr. Joana Goncalves notified Company of resignation on March 19, 2024.
Departure is to pursue another opportunity and not related to any disagreement.
She will remain CMO through April 16, 2024, assisting in transition.
Duties will be assumed by other senior management team members.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joana Goncalves

Chief Medical Officer

TVRD · Tvardi Therapeutics, Inc.

Effective: 2024-04-16
Filed: March 22, 2024, 7:59 PM ET

On March 19, 2024, Dr. Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc. (the “Company”), informed the Company of her intention to resign from her role effective April 16, 2024, to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joana Goncalves resigned as Chief Medical Officer at Tvardi Therapeutics, Inc..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On March 19, 2024, Dr. Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc. (the “Company”), informed the Company of her intention to resign from her role effective April 16, 2024, to pursue another opportunity.

View on SEC.gov

Tvardi Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-037855

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.